GENEVA, June 19 -- JIANGSU ALPHAMAB BIOPHARMACEUTICALS CO., LTD. filed a patent application (CN2025/134090) for “BISPECIFIC ANTIBODY-MULTIPLE-PAYLOAD CONJUGATE”. With publication no. WO/2026/103680, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 47/68
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....